Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lang

Showing results (701-710 of 809) with videos related to

Pageof 81
Sort By:
European Journal of Heart Failure|December 5, 2019
The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approachMartijn F Hoes, Jasper Tromp, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|March 24, 2021
Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study)Pankaj Gupta, Adriaan A Voors, Prashanth Patel, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 1, 2020
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fractionJozine M Ter Maaten, Pieter Martens, Kevin Damman, et al.
European Journal of Heart Failure|April 30, 2016
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHFAdriaan A Voors, Stefan D Anker, John G Cleland, et al.
European Journal of Heart Failure|January 4, 2023
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndromeCamilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, et al.
European Journal of Heart Failure|March 8, 2019
Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failureJozine M Ter Maaten, Daan Kremer, Biniyam G Demissei, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 20, 2021
The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failurePaloma Pandhi, Koen W Streng, Stefan D Anker, et al.
Journal of the American College of Cardiology|October 21, 2017
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF SubanalysisAntoni Bayes-Genis, Julio Núñez, Faiez Zannad, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2022
Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart FailureJohanna E Emmens, Martin H de Borst, Eva M Boorsma, et al.
Pageof 81

Showing results (701-710 of 809) with videos related to

Sort By:
Pageof 81
European Journal of Heart Failure|December 5, 2019
The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approachMartijn F Hoes, Jasper Tromp, Wouter Ouwerkerk, et al.
European Journal of Heart Failure|March 24, 2021
Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study)Pankaj Gupta, Adriaan A Voors, Prashanth Patel, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 1, 2020
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fractionJozine M Ter Maaten, Pieter Martens, Kevin Damman, et al.
European Journal of Heart Failure|April 30, 2016
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHFAdriaan A Voors, Stefan D Anker, John G Cleland, et al.
European Journal of Heart Failure|January 4, 2023
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndromeCamilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, et al.
European Journal of Heart Failure|March 8, 2019
Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failureJozine M Ter Maaten, Daan Kremer, Biniyam G Demissei, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 20, 2021
The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failurePaloma Pandhi, Koen W Streng, Stefan D Anker, et al.
Journal of the American College of Cardiology|October 21, 2017
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF SubanalysisAntoni Bayes-Genis, Julio Núñez, Faiez Zannad, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2022
Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart FailureJohanna E Emmens, Martin H de Borst, Eva M Boorsma, et al.
Pageof 81